Hypoxia and Medicine - Hypoxia Symptoms News

Hypoxia Symptoms News

Thermal shelters, DRDO's latest 'weapon' to ease soldiers' pain in high altitudes Monday, July 4, 2011 @ 1:09AMThe much-maligned DRDO has developed and implemented several new initiatives designed to make life easier for the Indian soldier stationed in high altitude areas, reports RS Chauhan
Marine life on brink of extinction - report Tuesday, June 21, 2011 @ 1:28AMScientists have warned that pollution and global warming are pushing the world's oceans to the brink of a mass extinction of marine life.
E Coli: Avoiding foodborne disease Tuesday, June 14, 2011 @ 7:26PMNo one knows when or where E Coli may appear next. Precautions in eating, cooking and hygiene are never too early.
Sleep Disruptions May Be a Function of Combat, Not Specific to PTSD or Other Medical Disorders Sunday, May 15, 2011 @ 11:30AMA study presented today at the American Psychiatric Association's annual meeting suggests that sleep disturbances like obstructive sleep apnea , excessive awakening and insomnia, may be a normal result of combat experience, rather than a symptom of post-traumatic stress disorder , traumatic brain injury , major depression or other psychiatric conditions.
New Study Shows Tapentadol Extended Release (ER) May Significantly Reduce Average Pain Intensity for Diabetic Patients ... Friday, January 28, 2011 @ 9:01AMRARITAN, N.J., Jan. 28, 2011 /PRNewswire/ -- New research has been published indicating that patients suffering from a painful complication of diabetes may experience a significant improvement in their pain as measured by a pain intensity scale when using an investigational pain medication. This phase III study, which evaluates the safety and efficacy of tapentadol ER against placebo for ...
New Study Shows Tapentadol Extended Release (ER) May Significantly Reduce Average Pain Intensity for Diabetic Patients ... Friday, January 28, 2011 @ 7:30AMNew research has been published indicating that patients suffering from a painful complication of diabetes may experience a significant improvement in their pain as measured by a pain intensity scale when using an investigational pain medication. Â This phase III study, which evaluates the safety and efficacy of tapentadol ER against placebo for relieving moderate to severe chronic pain ...
Aeolus Pharmaceuticals’ AEOL 10150 Promotes Survival in Non-Human Primates Exposed to Lethal Doses of Radiation Tuesday, November 2, 2010 @ 8:11AMMISSION VIEJO, Calif.--(BUSINESS WIRE)--Aeolus Pharmaceuticals, Inc. (OTCBB:AOLS) today announced preliminary results showing that AEOL 10150 promotes survival in a proof of principle study conducted in a non-human primate model of Pulmonary Acute Radiation Syndrome (ARS). The study included 13 animals, of which 6 were control animals and 7 received AEOL 10150. While none of the six control ...
Aeolus Pharmaceuticals’ AEOL 10150 Promotes Survival in Non-Human Primates Exposed to Lethal Doses of Radiation Tuesday, November 2, 2010 @ 8:00AMAeolus Pharmaceuticals, Inc. today announced preliminary results showing that AEOL 10150 promotes survival in a proof of principle study conducted in a non-human primate model of Pulmonary Acute Radiation Syndrome .
First person: How I trained to fly in space Monday, October 18, 2010 @ 10:14AMReporter has wild trip in preparation for private space tourist flight, culminating in a centrifuge ride that packed on a walloping six times the normal force of gravity.
A possible role for Smurf1 in pulmonary arterial hypertension Monday, June 21, 2010 @ 11:53AMPulmonary arterial hypertension (PAH) is a progressive disease, marked by shortness of breath and fatigue which can be fatal if untreated. Increased pressure in the pulmonary artery and its branches is associated with dysfunctional growth control of endothelial and smooth muscle cells leading to excessive thickening of the blood vessel wall, obliteration of the lumen and right heart failure.
A possible role for Smurf1 in pulmonary arterial hypertension Monday, June 21, 2010 @ 10:47AM( Society for Experimental Biology and Medicine ) Pulmonary arterial hypertension is a progressive disease, marked by shortness of breath and fatigue which can be fatal if untreated. Increased pressure in the pulmonary artery and its branches is associated with dysfunctional growth control of endothelial and smooth muscle cells leading to excessive thickening of the blood vessel wall ...
Genzyme Receives FDA Approval for Lumizyme for Pompe Disease Tuesday, May 25, 2010 @ 10:06AMCAMBRIDGE, Mass.----Genzyme Corporation announced today that the FDA has granted U.S. marketing approval for Lumizyme™ , produced at the 4000 liter bioreactor scale at its manufacturing facility in Geel, Belgium.
Exelixis Reports Encouraging Interim Data from an Ongoing Adaptive Randomized Discontinuation Trial of XL184 in ... Thursday, May 20, 2010 @ 6:45PMExelixis, Inc. (NASDAQ:EXEL) today reported interim data from an ongoing adaptive randomized discontinuation trial (RDT) of single agent XL184 in ...
Exelixis Reports Encouraging Interim Data from an Ongoing Adaptive Randomized Discontinuation Trial of XL184 in ... Thursday, May 20, 2010 @ 6:35PMSOUTH SAN FRANCISCO, Calif.----Exelixis, Inc. today reported interim data from an ongoing adaptive randomized discontinuation trial of single agent XL184 in patients with melanoma, non-small cell lung cancer , small cell lung cancer , hepatocellular carcinoma , pancreatic, gastric/GE junctional, prostate, ovarian, or breast cancer who have measurable disease and had undergone up to 3 prior lines ...
Tapentadol Data to Be Presented at 2010 American Pain Society Annual Meeting Monday, May 3, 2010 @ 7:00AMData on tapentadol for the relief of acute and chronic pain, as well as patient and prescriber perceptions of oxycodone immediate-release treatments, will be presented at the 29th Annual Scientific Meeting of the American Pain Society May 6-8, 2010.
New and Exciting in PLoS ONE [A Blog Around The Clock] Wednesday, February 17, 2010 @ 7:47AMThere are 31 new articles in PLoS ONE today. As always, you should rate the articles , post notes and comments and send trackbacks when you blog about the papers. You can now also easily place articles on various social services (CiteULike, Mendeley, Connotea, Stumbleupon, Facebook and Digg) with just one click. Here are my own picks for the week - you go and look for your own favourites ...
Gardener killed by cut to a finger Thursday, January 21, 2010 @ 12:18AMA KEEN gardener died after he cut his finger while enjoying his favourite pastime.
News From The Journal Of Clinical Investigation: Dec. 14, 2009 Tuesday, December 15, 2009 @ 7:19AMVASCULAR BIOLOGY: Signaling decreased blood pressure Blood pressure is controlled in part by changes in the radius of blood vessels; when the smooth muscle cells in the wall of a blood vessel contract, the radius of the blood vessel decreases and blood pressure increases. A team of researchers at CSIC-University of Salamanca, Spain, has now identified in mice a new signaling pathway that ...
Foxy lady has the right moves aloft Thursday, December 3, 2009 @ 11:38AMLANGKAWI: If not for her flying suit, Major Patricia Yapp Syau Yin could be mistaken for a schoolgirl visiting Lima '2009.
Foxy lady has the right moves aloft Wednesday, December 2, 2009 @ 8:30PMLANGKAWI: If not for her flying suit, Major Patricia Yapp Syau Yin could be mistaken for a schoolgirl visiting Lima '2009. But the demure, well-mannered "foxy lady" packs enough punch to pull 9Gs (n...
Data Demonstrating Aeolus Pharmaceuticals' AEOL 10150's Efficacy as a Broad Spectrum Countermeasure Against ... Thursday, November 5, 2009 @ 8:44AMMISSION VIEJO, Calif.----Aeolus Pharmaceuticals, Inc. announced today the presentation of data at the GHSI Public Health Emergency Medical Countermeasures Workshop detailing the potential of AEOL 10150 as a broad spectrum medical countermeasure to treat radiological and chemical threats.
Compugen Announces Preeclampsia Biomarker Collaboration Thursday, November 5, 2009 @ 6:00AMTEL AVIV, Israel----Compugen Ltd. announced today that it has signed a research and license agreement with a leading diagnostic company covering CGEN-226, a novel biomarker candidate for early detection of preeclampsia.
H1N1 disproportionately infecting, killing young people: U.S. study Wednesday, November 4, 2009 @ 2:51PMAs the sudden deaths of young children from H1N1 drive unprecedented demand for flu vaccine, a new study of the first 1,000 cases in California of H1N1 hospitalizations and deaths confirms the pandemic virus is disproportionately infecting and killing young people.
First foreign fatality on mainland Tuesday, November 3, 2009 @ 9:03PM&$ &$A man wearing a mask photographs a monument of the goddess of the hunt, Diana, and her dogs, also wearing protective masks, in the Ukrainian city of Lviv Tuesday. The Ukrainian health ministry has raised the death toll from the flu and respiratory problems to 67. Photo: AFP&$ &$ A Russian man who flew from his home country to Beijing on October 28 died of the A(H1N1) virus Monday, ...
Fiesta Movement Agents Surpass 1 Million Miles, Show That They Go Hand-In-Hand With Adventure Tuesday, October 27, 2009 @ 6:00AM-
Animal Data Demonstrating Aeolus Pharmaceuticals' AEOL 10150's Efficacy in Mitigating Radiation Damage to the Lung ... Thursday, October 15, 2009 @ 10:19AMMISSION VIEJO, Calif.----Aeolus Pharmaceuticals, Inc. announced today the presentation of data at the 55th Annual Meeting of the Radiation Research Society detailing the effectiveness of AEOL 10150 as a countermeasure to radiation exposure in the lungs in mice.
LIVESHOTS: Flu Gone to the Dogs Wednesday, October 14, 2009 @ 1:34PMAs the H1N1 virus tries to wiggle its way into as many of us as it can this flu season, there is another virus, H3N8, that is threatening dogs this year. H3N8, or Canine Influenza, is not contagious for us homo sapiens, but for dogs it can be deadly.
Re-evaluate how you apply nitrogen this fall Wednesday, October 7, 2009 @ 12:44AMSharon Kuhns, University of Illinois Extension in Coles County
Aeolus Pharmaceuticals Completes $1.65 Million Financing, Converts $1 Million in Debt to Common Stock and Receives an ... Tuesday, October 6, 2009 @ 3:30PMMISSION VIEJO, Calif.----Aeolus Pharmaceuticals, Inc. announced today that it has completed a $1.65 million financing with several existing institutional shareholders, all of which are affiliates of Xmark Opportunity Partners, LLC.
Airplanes, oxygen and the media Thursday, September 24, 2009 @ 8:14PMWhy do people keep insisting that pilots manipulate the air supply in planes? It ain't true, folks
Aeolus Pharmaceuticals Initiates Second Study of AEOL 10150 as a Countermeasure to Radiation Exposure in Mice Monday, September 14, 2009 @ 8:00AMMISSION VIEJO, Calif.----Aeolus Pharmaceuticals, Inc. announced today the initiation of a second study, in mice, to determine the optimal length of treatment with AEOL 10150 when used as a countermeasure to Acute Radiation Syndrome in the lungs.
Aeolus Pharmaceuticals Submits White Paper to BARDA for Funding of AEOL 10150 as a Countermeasure to Lung Injury Due ... Friday, September 11, 2009 @ 8:00AMMISSION VIEJO, Calif.----Aeolus Pharmaceuticals, Inc. announced today that it has submitted a white paper to the Biomedical Advanced Research and Development Authority in response to Special Instructions Amendment 4 to a Broad Agency Announcement for advanced research and development of medical countermeasures for chemical, biological, radiological and nuclear threats.
NTSB: Pilot's lack of oxygen linked to 2007 crash that killed 9 Snohomish-based sky divers Friday, July 3, 2009 @ 12:47PMThe pilot in a 2007 crash near White Pass that killed him and nine Snohomish-based skydivers was likely impaired by a lack of oxygen when the plane stalled out, according to the National Transportation Safety Board.
NTSB says pilot suffered from lack of oxygen before 2007 crash Friday, July 3, 2009 @ 1:26AMFrom left, Erin Effmann, Wanda Craig, Rich Williams, and Heidi Barker comfort each other at the command center for the search and rescue efforts of the nine skydivers and pilot who crashed near Shoe Lake on Monday.
NUCYNTA(TM) (tapentadol) CII Immediate Release Tablets Now Available For Relief Of Moderate To Severe Acute Pain Wednesday, June 24, 2009 @ 8:15AMPatients suffering from acute pain and healthcare professionals who treat pain have a new treatment option: NUCYNTA(TM) (tapentadol) CII immediate release tablets.
Tips from the American Journal of Pathology Tuesday, June 23, 2009 @ 11:18PM( American Journal of Pathology ) The following highlights summarize research articles that are published in the current issue of the American Journal of Pathology.
New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal Tuesday, May 26, 2009 @ 7:00AMData Confirm Tapentadol Efficacy and Tolerability for Acute Pain Patients
Larger Numbers of Workers in Jilin City Poisoned By Toxic Gas Friday, May 15, 2009 @ 10:21AMThousands of workers from the Jilin Chemical Fiber Co. Ltd. (JCF) are suspected to be poisoned by...